Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Nectar Lifesciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2005
Last close ₹10.20down ₹0.13 (1.26%)BSE ₹10.29
Share price at the NSE close on 30 Oct 2026. Previous close ₹10.33.
30 Oct: open ₹10.43, high ₹10.43, low ₹9.82
52-week range of traded prices to 30 Oct 2026
₹9.30Low, 30 Mar 2026₹22.40High, 23 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹198 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 95,05079.2% delivered
Nectar Lifesciences share news and announcements
590 announcements, routine notices left out, newest first. Page 10 of 12.
May 2013
15 May · Results
15 May · Dividend
Board of Directors in their meeting held on May 15, 2013 have recommended 10% Final Dividend i.e. Re 0.10/- per equity share to the members of the company, out of profits of the company for the financial year 2012-13, subject to the approval of the members in their Annual General meeting.6 May · Board meeting
Inter alia, to consider and approve the following: (1) The Audited Financial Results for Financial Year 2012-13, Balance Sheet of the Company as at March 31, 2013 and Profit A Loss Accounts for the financial year ended on March 31, 2013 and matters related thereto, (2) Recommendation of final dividend to the Members of the Company for Financial Year 2012-13.
Feb 2013
5 Feb · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on December 31, 2012.
Nov 2012
1 Nov · Management
Board of Directors on November 01, 2012 has appointed Mr. Harparkash Singh Gill on the Board as Wholetime Director [designated as President (Operation) & Director] for a period of three years w.e.f. November 01, 2012, subject to approval of shareholders.
Oct 2012
25 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the period ended on September 30, 2012.1 Oct · Dividend
Members in their Annual General Meeting held on September 29, 2012 have declared the Final Dividend of Re.0.10/- per equity share (10% on the face value of Re.1/- per equity share) for the financial year 2011-12. The Dividend will be paid latest by October 28, 2012.1 Oct · Disclosure of Voting Pattern - Clause 35A
Aug 2012
17 Aug · Meeting
Annual General Meeting of the Company will be held on September 29, 2012. The Register of Members and the Share Transfer Books will remain closed from September 22, 2012 to September 29, 2012 (Both days inclusive) for the purpose of Annual General Meeting and dividend, if any, declared by member in the Annual General Meeting.10 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 09, 2012, have inter alia decided and approved : (1) To commence a new business regarding 'Manufacturing and Processing of Agro based Products' more specifically provided in other objects No. 21, 22 and 23 of Memorandum and Articles of Association of the Company and proposed a special Resolution under Section 149(2A) of the Companies Act, 1956 in the forthcoming Annual General Meeting.10 Aug · Dividend
Board of Directors of the Company at its meeting held on August 09, 2012, inter alia decided and approved the recommendation of 10% Final Dividend i.e. Re 0.10/- per equity share to the members of the company, out of profits of the Company for the Financial year 2011-12.1 Aug · Board meeting
To consider and approve, inter alia amongst items, : (1) The Unaudited Financial Results of the Company for the quarter ended on June 30, 2012; (2) The Audited Financial Results for Financial Year 2011-12, Balance Sheet of the Company as at March 31, 2012 and Profit & Loss Accounts for the financial year ended on March 31, 2012 and matters related thereto; (3) To convene the Annual General Meeting of Members of the Company for the financial Year 2011-12 and matters related thereto.(4)Recommendation of final dividend to the Members of the company for Financial Year 2011-12 and fix the Book closure dates and matters related thereto.
Jul 2012
31 Jul · Management
Mr. Dinesh Dua has resigned as Chief Executive Officer and Director from the company w.e.f. July 31, 2012.
May 2012
14 May · Management
Board of Directors of the Company in their meeting held on May 14, 2012 have re-appointed Mr. Sanjiv Goyal as an Chairman & Managing Director of the Company for a period of 5 years from June 01, 2012.14 May · Results
5 May · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on March 31, 2012.
Feb 2012
1 Feb · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on December 31, 2011.
Dec 2011
Nov 2011
Oct 2011
31 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on September 30, 2011.
Sep 2011
30 Sep · Dividend
Members in their Annual General Meeting held on September 30, 2011 have declared the Final Dividend of Re.0.10/- per equity share (10% on the face value of Re.1/- per equity share) for the financial year 2010-11. The Dividend will be paid latest by October 29, 2011.
Aug 2011
16 Aug · Meeting
Annual General Meeting of the Company will be held on September 30, 2011. The Register of Members and the Share Transfer Books will remain closed from September 23, 2011 to September 30, 2011 (Both days inclusive) for the purpose of Annual General Meeting and dividend, if any, declared by member in the Annual General Meeting.12 Aug · Dividend
Board of Directors in their meeting held on August 12, 2011 have inter alia decided and approved : (1) The recommendation of 10% Final Dividend i.e, Re. 0.10/- per equity share to the members of the Company, out of profits of the Company for the Financial year 2010-11.12 Aug · Results
4 Aug · Board meeting
To consider and approve, inter alia amongst items, : (1) The Unaudited Financial Results of the Company for the quarter ended on June 30, 2011; (2) The Audited Financial Results for Financial Year 2010-11, Balance Sheet of the Company as at March 31, 2011 and Profit & Loss Accounts for the financial year ended on March 31, 2011 and matters related thereto; (3) To convene the Annual General Meeting of Members of the Company for the financial Year 2010-11 and matters related thereto.
May 2011
12 May · Results
3 May · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on March 31, 2011.
Apr 2011
26 Apr · FCCBs
Company has made payment towards redemption of outstanding FCCBs of Nominal Value US$ 33 million, which were due for redemption on April 26, 2011 (Maturity Date), at the redemption price of 150.71% of its principal amount, as per the terms and conditions of the FCCBs issue. The Company has paid an aggregate amount of US$ 49.7343 million consisting of payment of the principle amount US$33 million and accumulated premium on redemption of the FCCBs of US$ 16.7343 million.
Mar 2011
Jan 2011
4 Jan · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on December 31, 2010.
Nov 2010
9 Nov · Management
Board of Directors of the Company in their meeting held on November 08, 2010 have re-appointed Mr. Aryan Goyal as an Executive Director of the company for a period of 5 years from December 05, 2010.
Oct 2010
28 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on September 30, 2010.
Sep 2010